|
|
 |
AEMCOLO Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
MICROCRYSTALLINE CELLULOSE 102 Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
MEDIUM-CHAIN TRIGLYCERIDES Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
MODIFIED CORN STARCH Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|